US-based specialty pharmaceutical company, pSivida has entered into a funded technology evaluation agreement with an undisclosed pharmaceutical company. The deal will assess the Durasert technology, pSivida's core technology system, for ...
pSivida has signed a funded technology evaluation agreement with a biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology in the field of ophthalmology. Tethadur, which uses an injectable, ...